Increasing resilience of medical supply chains during the COVID-19 pandemic
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Why building future resilience requires a delicate balance between increased flexibility, efficiency and welfare advantages of GVCs.
Integration of manufacturing firms in global value chains offers opportunities for countries to raise employment, exports and productivity.
The recovery of supply chains can be supported through trade policies and firm-specific initiatives.
COVID-19 struck at the core of GVC hub regions, with severe implications for international production networks.